Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
- PMID: 36532003
- PMCID: PMC9748735
- DOI: 10.3389/fimmu.2022.1099535
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Abstract
[This corrects the article DOI: 10.3389/fimmu.2022.865241.].
Keywords: animal model; autoimmunity; epidermolysis bullosa acquisita; mucous membrane pemphigoid; neutrophils; pemphigoid; phosphatidylinositol 3-kinase (P13k); signal transduction.
Copyright © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.
Erratum for
-
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.Front Immunol. 2022 Sep 28;13:865241. doi: 10.3389/fimmu.2022.865241. eCollection 2022. Front Immunol. 2022. PMID: 36248903 Free PMC article.
Similar articles
-
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases.Front Immunol. 2022 Sep 28;13:865241. doi: 10.3389/fimmu.2022.865241. eCollection 2022. Front Immunol. 2022. PMID: 36248903 Free PMC article.
-
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.An Bras Dermatol. 2019 Apr;94(2 Suppl 1):33-47. doi: 10.1590/abd1806-4841.2019940207. Epub 2019 Jun 30. An Bras Dermatol. 2019. PMID: 31166405 Free PMC article.
-
Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence.J Cutan Med Surg. 2018 Jan/Feb;22(1):22-24. doi: 10.1177/1203475417722734. Epub 2017 Jul 18. J Cutan Med Surg. 2018. PMID: 28719980
-
A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita.Am J Clin Dermatol. 2020 Aug;21(4):557-565. doi: 10.1007/s40257-020-00513-3. Am J Clin Dermatol. 2020. PMID: 32180161 Review.
-
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4. Clin Rev Allergy Immunol. 2018. PMID: 28779299 Review.
Cited by
-
[Immunopathogenesis of mucous membrane pemphigoid].Ophthalmologie. 2023 May;120(5):462-471. doi: 10.1007/s00347-023-01858-w. Epub 2023 May 2. Ophthalmologie. 2023. PMID: 37129642 Review. German.
-
Autoimmunity against laminin 332.Front Immunol. 2023 Aug 10;14:1250115. doi: 10.3389/fimmu.2023.1250115. eCollection 2023. Front Immunol. 2023. PMID: 37638011 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources